Reducing cardiovascular risk in high-risk patients with diabetes/metabolic syndrome

被引：0
|
作者：
Weissman, Peter [1 ,2 ]
Davidson, Michael [3 ]
机构：
[1] Univ Miami, Sch Med, Internal Med Endocrinol, Coral Gables, FL 33124 USA
[2] Osteoporosis Ctr, Miami, FL USA
[3] Univ Chicago, Pritzker Sch Med, Prevent Cardiol, Chicago, IL 60637 USA
来源：
POST ACCORD PERSPECTIVES: THE ROLE OF FENOFIBRATES: TRANSLATING THE EVIDENCE-BASED MEDICINE AND SCIENCE INTO CLINICAL PRACTICE FOR THE PRIMARY CARE PROVIDER | 2010年 / 274卷
关键词：
EXTREMITY ARTERIAL-DISEASE; TERM FENOFIBRATE THERAPY; TYPE-2; DIABETES-MELLITUS; ATHEROSCLEROSIS INTERVENTION; METABOLIC-SYNDROME; DOUBLE-BLIND; 9795; PEOPLE; MEN; BEZAFIBRATE; PREVENTION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：26 / 42
页数：17
相关论文
共 50 条
  • [1] Metabolic Syndrome and retinal Vessel Diameter in cardiovascular High-Risk Patients
    Ruchalla, Elke
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2017, 234 (01)
  • [2] The Effect of Metabolic Syndrome on Global Cardiovascular Risk Reduction in High-Risk Patients with Dyslipidemia on Pharmacotherapy
    Farahani, Pendar
    Levine, Mitchell
    Ellrodt, Gray
    CIRCULATION, 2009, 119 (10) : E343 - E343
  • [3] Metabolic syndrome in high cardiovascular risk patients
    Gaudio, G
    Schizzarotto, A
    Margaroli, P
    Bossi, P
    Riganti, G
    Cosini, I
    Daverio, A
    Rotolo, F
    Guasti, L
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 106A - 107A
  • [4] Importance of new criteria of metabolic syndrome in determination of high-risk cardiovascular patients
    Chulaievska, I.
    Romanov, V.
    Ilyushina, A.
    Mitchenko, O.
    JOURNAL OF HYPERTENSION, 2007, 25 : S197 - S197
  • [5] Dalcetrapib in high-risk patients with type 2 diabetes mellitus and/or metabolic syndrome
    Stalenhoef, A. F. H.
    Davidson, M. H.
    Robinson, J. G.
    Duttlinger-Maddux, R.
    Kallend, D.
    Bays, H.
    DIABETOLOGIA, 2009, 52 : S487 - S487
  • [6] Metabolic syndrome: A marker of patients at high cardiovascular risk
    Lau, David C. W.
    Yan, Hongyun
    Dhillon, Bikramjit
    CANADIAN JOURNAL OF CARDIOLOGY, 2006, 22 : 85B - 90B
  • [7] Metabolic Syndrome, Diabetes, and Cardiovascular Risk in HIV
    Nix, Linda M.
    Tien, Phyllis C.
    CURRENT HIV/AIDS REPORTS, 2014, 11 (03) : 271 - 278
  • [8] Metabolic Syndrome, Diabetes, and Cardiovascular Risk in HIV
    Linda M. Nix
    Phyllis C. Tien
    Current HIV/AIDS Reports, 2014, 11 : 271 - 278
  • [9] Metabolic syndrome - a high cardiovascular risk?
    Toplak, H
    ACTA MEDICA AUSTRIACA, 2004, 31 (03) : 63 - 66
  • [10] High-dose atorvastatin provides sustained benefit in reducing risk of cardiovascular disease among patients with diabetes or metabolic syndrome
    Deedwania, P.
    La Rosa, J. C.
    Shepherd, J.
    DIABETOLOGIA, 2008, 51 : S545 - S546
12345